healthcare News
Biotech stocks rally as FDA biologics chief Prasad to depart
Leadership change raises hopes for smoother drug approvals after regulator's controversial decisions
Xenon surges 47% on successful epilepsy drug trial
Phase 3 study shows 53% seizure reduction, positions company for 2026 FDA approval
enGene beats Q1 estimates, cash runway extends to 2028
Biotechnology company posts $0.44 loss per share, exceeds analyst expectations as BLA filing for detalimogene remains on track
Cartesian Therapeutics plunges on massive $5.02 EPS miss, revenue collapse
Biotech's revenue falls 93% year-over-year to $2.8M amid collaboration shortfall, net loss widens to $130.3M
ARS Pharmaceuticals surges on neffy sales beat, China approval
Needle-free epinephrine spray generates $72.2M in first year as European regulator backs pediatric expansion
J&J wins FDA approval for multiple myeloma drug combo
Tecvayli and Darzalex Faspro combination cleared after demonstrating strong Phase 3 survival data
OptimizeRx plunges 4% on flat 2026 guidance despite record Q4 beat
Massive earnings overshadowed by CEO's warning on pricing uncertainty and muted growth outlook
Metagenomi plunges 67% on earnings miss, collaboration revenue collapse
Gene editing biotech reports $87.9M net loss as revenue tumbles 51.8%, but $160.8M cash provides runway